Malocclusion
Conditions
Keywords
Rapid orthodontics, accelerated orthodontics, Piezocision, flapless corticotomies, minimaly invasive
Brief summary
INTRODUCTION: Dentoalveolar surgeries such as piezocision, have been developed with the aim to accelerate the tooth movement and therefore reduce the length of orthodontic treatment. Although this surgical technique seems to present several advantages, such as decreased risk of decalcification or orthodontic relapse, its use as a routine practice is not yet recommended. The main purpose of this study is to determine the duration of orthodontic treatment by using the piezocision. The secondary objectives are to evaluate the effect of this surgical technique on bone density, root resorption, osteoclast activity, inflammatory events and pain assessment. MATERIAL AND METHODS: The investigators will conduct a prospective study. The experimental group will consist of 14 adults, subjects from 18 to 40 years-old (10 women, 4 men). The control group will consist of 30 matched patients, who have been already treated in the orthodontic clinic of the University of Montreal. The reliabilities of Intra and Inter assesors will be measured for each doctor. After completion of the surgical guides from CBCT, the Piezocision will be performed the same day of the bracket indirect placement. The surgical procedure will be standardized and did it by the same surgeon. The appointments will be every 2 weeks for 4 months, then every month. The investigators will make an assessment of pain by using a numerical visual scale, during the first 7 days after surgery. Analysis of inflammatory markers (IL-1) and osteoclast activity (RANKL, OPG) will be evaluated from the gingival sulcus fluid collected at day 0, 1, 3, 5, 8, 12, 16 and 24 weeks. At the end of the treatment, the overall quality evaluation of treatment using the American Board of Orthodontics' grading system would be realized by two blind external observers to limit bias.
Detailed description
EXPECTED RESULTS Orthodontic treatment accelerated by piézocicison will be completed within one year and will be 50% faster than a traditional treatment. The ratio benefit / risk of performing the piezocision will be acceptable for the patient and the orthodontist. We expect the following results: low pain, and absence of dental and periodontal deleterious effect (no root resorption, no tooth vitality loss and no bone loss). The same cohort can be used in future studies to assess the long term stability of the treatment.
Interventions
PROCEDUREPiezocision
Flapless corticotomies
Sponsors
Université de Montréal
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes
Inclusion criteria
* normal or low skeletal problem; * dental relationchip without extraction; * healthy; * complete adult teeth; * very cooperative; * no plaque; * no active periodontal disease and no bone loss visible radiographically; * patient wishing a shorter orthodontic treatment.
Exclusion criteria
* patient regularly taking analgesic and antidepressants. * patients with alcool abuse problems. * patient smoking more than 10 cigarettes per day. * pregnant patient. * allergy to non-steroidal anti-inflammatory drugs. * local or systemic Immunodeficiencies. * uncontrolled systemic disease (For exaemple diabetes, cardiovascular disease). * coagulation problems or taking anti-coagulants. * presence of oral infections and periodontal disease uncontrolled active. * taking intravenous bisphosphonates or taking oral bisphosphonates for more than 4 years. * taking a long-term corticosteroids. * antibiotic necessary before any surgery and taking antibiotics within 6 months before surgery
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Determine the duration of orthodontic treatment associated with Piezocision | 18 months | Assessment of the length of orthodontic treatment following piezocision |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Assess the overall quality of treatment (American Board of Orthodontics' grading system) | 18 months | At the end of the treatment, the overall quality evaluation of treatment using the American Board of Orthodontics' grading system would be realized by two blind external observers to limit bias. |
| Assessment of pain during treatment (numerical visual scale) | Every days after the surgery durin 7 days and one day after every appointment | Assessment of pain by Visual Digital Scale during treatment |
| Evaluation of osteoclastic activity (analysis of RANKL and OPG markers by sampling in the gingival fluid with sterile paper points) | weeks 0, 1, 3, 5, 8, 12, 16, 24 | Osteoclastic activity measurement by analysis of RANKL and OPG markers by sampling in the gingival fluid with sterile paper points |
| Compare the duration of treatment with the control group | 18 months | Compare the duration of treatment to the control group already processed and matched by sex, age, type of malocclusion, orthodontic biomechanics to limit bias. |
| Evaluate changes in density and bone volume with the cone beam computed tomography or Cone Beam Computerized Tomography (CBCT) | 18 months | Evaluate changes in density and bone volume with the cone beam computed tomography or Cone Beam Computerized Tomography (CBCT) |
| Evaluate root resorption with the Cone Beam Computerized Tomography (CBCT) | 18 months | Evaluation of root resorption using CBCT |
| Evaluate the inflammatory and remodelling gene expression | 0 and 8 weeks | Evaluation of the gene expression associated with inflammation following piezocision |
| Evaluation of inflammatory markers (quantification of interleukin-1 (IL-1)) | weeks 0, 1, 3, 5, 8, 12, 16, 24 | Measurement of inflammatory markers in the gingival fluid with the quantification of interleukin-1 (IL-1) |
Countries
Canada
Outcome results
None listed